Skip to content Skip to sidebar Skip to footer
Subscribe Now
PharmaShots Interview Sanofi’s Chris Soria Shares Insights on Amcenestrant for the Treatment of Breast Cancer
VIEWPOINTS

PharmaShots Interview: Sanofi’s Chris Soria Shares Insights on Amcenestrant for the Treatment of Breast Cancer

In an interview with PharmaShots, Chris Soria, Global Project Head of Amcenestrant at Sanofi shared his views on the updated data of Amcenestrant in the P-I/II (AMEERA-1) study for ER+/HER2−metastatic breast cancer, presented at SABCS 2021 Shots: The P-I/II (AMEERA-1) study evaluated amcenestrant as monothx. & in combination with targeted therapies in postmenopausal women with ER+/HER2- MBC In a pooled analysis of 35…
April 20, 20220Comments

Read more

PharmaShots Interview Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy Infants Born at Term or Late Preterm
VIEWPOINTS

PharmaShots Interview: Jon Heinrichs of Sanofi Pasteur & Tonya Villafana of AstraZeneca Shares Insights on Nirsevimab in Healthy Infants Born at Term or Late Preterm

In an interview with PharmaShots, Jon Heinrichs, Associate, Vice President, and the Head of Innovation and Emerging Sciences at Sanofi Pasteur & Tonya Villafana, Vice President, Global Franchise Head, Infection at AstraZeneca share their views on the data of Nirsevimab in P-III (MELODY) trial to protect infants against Respiratory Syncytial Virus Shots: The P-III (MELODY) trial evaluates nirsevimab (50/100mg, IM) vs…
April 19, 20220Comments

Read more

PharmaShots Interview Reproductive Solutions’ Diana Peninger Shares Insights on ProteX, a Solution for Male Infertility
VIEWPOINTS

PharmaShots Interview: Reproductive Solutions’ Diana Peninger Shares Insights on ProteX, a Solution for Male Infertility

In an interview with PharmaShots, Diana Peninger, President and CEO at Reproductive Solutions shares her views on the ProteX sperm collection solution, offering a new hope for infertile couples. Shots: Reproductive Solutions (RSI) reported the availability of a patented, FDA-listed semen collection container that improves specimen quality for in vitro fertilization and other assisted reproductive technologies The ProteX container…
April 18, 20220Comments

Read more

Disease of the Month: Chagas Disease (American Trypanosomiasis)
INSIGHTS+

Disease of the Month: Chagas Disease (American Trypanosomiasis)

INTRODUCTION Chagas disease also known by the name American trypanosomiasis, is a zoonotic infection, caused by protozoan flagellate Trypanosoma cruzi (kissing bugs). It is potentially a life-threatening infection transmitted to people and animals from the feces of blood-sucking bugs which belong to the subfamily of Triatominae2. Among all the vectors, Rhodnius proxilus, Panstrongylus megistus, and…
April 14, 20220Comments

Read more

PharmaShots Interview Fountain Therapeutics’ William Greene Shares Insights on the $15M Series A-2 Financing
VIEWPOINTS

PharmaShots Interview: Fountain Therapeutics’ William Greene Shares Insights on the $15M Series A-2 Financing

In an interview with PharmaShots, William Greene, CEO at Fountain Therapeutics shares his views on the closing of $15M Series A-2 financing & how it supports the drug discovery platform and pipeline Shots: The company closes $15M series A-2 financing bringing its total Series A funding to $26M which was led by Eli Lilly, Alexandria Venture Investments, and R42 Group as new…
April 13, 20220Comments

Read more

PharmaShots Interview Medidata’s Kelly McKee Shares Insight on Decentralized Clinical Trial
VIEWPOINTS

PharmaShots Interview: Medidata’s Kelly McKee Shares Insight on Decentralized Clinical Trial

In an interview with PharmaShots, Kelly McKee, Vice President, Patient Registries & Recruitment at Medidata shared her views on the decentralized clinical trial networks through the collaboration with Circuit Clinical Shots: Medidata is investing $27M in Circuit Clinical’s series C funding. Circuit Clinical will expand its DCT network to 500 physicians & 15M patients & bring clinical research as…
April 12, 20220Comments

Read more

PharmaShots Interview Abbott’s Allen Burton Shares Insight on Proclaim XR Spinal Cord Stimulation System for the Treatment of Chronic Intractable Pain of Trunk and Limbs
VIEWPOINTS

PharmaShots Interview: Abbott’s Allen Burton Shares Insight on Proclaim XR Spinal Cord Stimulation System for the Treatment of Chronic Intractable Pain of Trunk and Limbs

In an interview with PharmaShots, Dr. Allen Burton, Medical Director of Abbott’s Neuromodulation Business shared his views on the US FDA approval for expanded MRI compatibility of Its Proclaim XR SCS Device Shots: The US FDA has approved new expanded MRI compatibility for its Proclaim XR Spinal Cord Stimulation (SCS) System with Octrode leads. The Proclaim XR SCS System is an…
April 11, 20220Comments

Read more

PharmaShots Interview SOTIO Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced Metastatic Solid Tumors
VIEWPOINTS

PharmaShots Interview: SOTIO’ Richard Sachse Shares Insight on SOT101 for the Treatment of Advanced/Metastatic Solid Tumors

In an interview with PharmaShots, Richard Sachse, Chief Medical Officer & Managing Director at SOTIO shared his views on the data of SOT101 in the P-I/Ib (AURELIO-03) study for the treatment of advanced/metastatic solid tumors Shots: The P-I/Ib (AURELIO-03) study evaluates SOT101 as monothx. & in combination with pembrolizumab in patients with advanced/metastatic solid tumors The results showed that 13 patients…
April 6, 20220Comments

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]